Abstract
Histologic chorioamnionitis (HCA) is an intrauterine status of inflammation which may lead to the fetal inflammatory response syndrome. Inflammation is a pathogenetic mechanism also of preeclampsia, although not of microbial origin. The aim of the present pilot study was to evaluate the pattern of inflammatory cytokines in mothers and high-risk preterm infants during the perinatal period. Concentrations of proinflammatory and anti-inflammatory cytokines and C-reactive protein were evaluated in maternal, cord, and neonatal blood of very preterm infants <1,500 g birth weight. Histologic examinations of placentae and umbilical cords were performed. The 65 mother–neonate pairs enrolled were subdivided into three groups: (1) HCA group (n = 15), (2) preeclampsia group (n = 17), and (3) control group, in the absence of HCA/preeclampsia (n = 33). Maternal Interleukin (IL)-6 levels were significantly higher in women of the HCA group compared with the preeclampsia and control groups (p < 0.05). IL-22 was detected in nearly all maternal samples [median value 693.115 pg/ml (599.91–809.91 pg/ml)], with no statistical difference between the groups, but with a tendency to increased levels among preeclamptic women. Increased concentrations of IL-22 were detected in cord blood of neonates exposed to preeclampsia, compared with controls and infants exposed to HCA (p < 0.05). We speculate that the tendentially higher concentrations of IL-22 in preeclamptic mothers and the significantly higher concentrations in cord blood may reflect placental dysfunction and the underlying reparative processes at the maternal–fetal interface. Therefore, IL-22 could be an important biomarker of inflammation in preeclampsia.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12026-014-8568-2/MediaObjects/12026_2014_8568_Fig1_HTML.gif)
Similar content being viewed by others
References
Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179:194–202.
Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS. The fetal inflammatory response syndrome. 2007; doi:10.1097/GRF.0b013e31811ebef6.
Speer CP. Chorioamniotitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology. 2009; doi:10.1159/000209301.
Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology. 2011; doi:10.1159/000320170.
Schmidt B, Cao L, Mackensen-Haen S, Kendziorra H, Klingel K, Speer CP. Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol. 2001; doi:10.1067/mob.2001.13321.
May M, Marx A, Seidenspinner S, Speer CP. Apoptosis and proliferation in lungs of human fetuses exposed to chorioamnionitis. Histopathology. 2004; doi:10.1111/j.1365-2559.2004.01936.x.
Speer CP. Neonatal respiratory distress syndrome (RDS): an inflammatory disease? Neonatology. 2011; doi:10.1111/j.1365-2559.2004.01936.x.
Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001; doi:10.1210/jcem.86.6.7585.
Turunen R, Andersson S, Laivuori H, Kajantie E, Siitonen S, Repo H, Nupponen I. Increased postnatal inflammation in mechanically ventilated preterm infants born to mothers with early-onset preeclampsia. Neonatology. 2011; doi:10.1159/000325159.
Catarino C, Santos-Silva A, Belo L, Rocha-Pereira P, Rocha S, Patrício B, Quintanilha A, Rebelo I. Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood. J Pregnancy. 2012; doi:10.1155/2012/684384.
Campos-Cañas J, Romo-Palafox I, Albani-Campanario M, Hernández-Guerrero C. An imbalance in the production of proinflammatory and anti-inflammatory cytokines is observed in whole blood cultures of preeclamptic women in comparison with healthy pregnant women. Hypertens Pregnancy. 2014;33(2). doi:10.3109/10641955.2013.858744.
Beck T, Bahlmann F, Weikel W. Histology of chorioamnionitis: relations to maternal and fetal infection parameters. Z Geburtshilfe Perinatol. 1993;197(3):129–34.
ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. ACOG Committee on Obstetric Practice. Int J Gynaecol Obstet. 2002;77(1):67–75.
Gagliardi L, Macagno F, Pedrotti F, Coraiola M, Furlan R, Agostinis L, Milani S. Standard antropometrici neonatali prodotti dalla task-force della Società Italiana di Neonatologia e basati su una popolazione italiana nord-orientale. Riv Ital Pediatr (IJP). 1999;25:159–69.
Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol. 2004; doi:10.1016/j.ajog.2003.07.012.
Bersani I, Thomas W, Speer CP. Chorioamnionitis-the good or the evil for neonatal outcome? J Matern Fetal Neonatal Med. 2012; doi:10.3109/14767058.2012.663161.
Mühl H, Scheiermann P, Bachmann M, Härdle L, Heinrichs A, Pfeilschifter J. IL-22 in tissue-protective therapy. Br J Pharmacol. 2013; doi:10.1111/bph.12196.
Witte E, Witte K, Warszawska K, Sabat R, Wolk K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 2010; doi:10.1016/j.cytogfr.2010.08.002.
Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev. 2013; doi:10.1111/imr.12027.
Manaster I, Mandelboim O. The unique properties of uterine NK cells. Am J Reprod Immunol. 2010; doi:10.1111/j.1600-0897.2009.00794.x.
Brosnahan MM, Miller DC, Adams M, Antczak DF. IL-22 is expressed by the invasive trophoblast of the equine (Equus caballus) chorionic girdle. J Immunol. 2012; doi:10.4049/jimmunol.1103509.
Wang Y, Xu B, Li MQ, Li DJ, Jin LP. IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts. Int J Clin Exp Pathol. 2013;6(9):1781–90.
Kumar P, Rajasekaran K, Palmer JM, Thakar MS, Malarkannan S. IL-22: an evolutionary missing-link authenticating the role of the immune system in tissue regeneration. J Cancer. 2013; doi:10.7150/jca.5048.
Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009; doi:10.1016/j.immuni.2009.06.008.
Conflict of interest
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Iliana Bersani and Maria Pia De Carolis are co-authors.
Rights and permissions
About this article
Cite this article
Bersani, I., De Carolis, M.P., Foell, D. et al. Interleukin-22: Biomarker of maternal and fetal inflammation?. Immunol Res 61, 4–10 (2015). https://doi.org/10.1007/s12026-014-8568-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-014-8568-2